Production (Stage)
Autolus Therapeutics plc
AUTL
$1.54
$0.010.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.62% | -5.89% | -70.85% | -50.88% | -45.96% |
| Total Depreciation and Amortization | 26.50% | 17.53% | 16.32% | 1.08% | -9.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -77.19% | -45.78% | 96.96% | 175.57% | 111.90% |
| Change in Net Operating Assets | -306,577.78% | -8,201.03% | 118.01% | -21.92% | 99.90% |
| Cash from Operations | -67.96% | -41.68% | -42.75% | -23.29% | -20.04% |
| Capital Expenditure | -277.17% | -100.94% | -22.66% | 71.83% | 42.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -5,643.52% | -3,491.41% | -22.66% | 71.83% | 42.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.94% | 2,039,081.48% | 236.02% | 235.68% | 235.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 153.61% | 4,382.97% | -84.72% | -84.72% | -81.41% |
| Cash from Financing | -94.99% | 66,867.16% | 151.38% | 151.18% | 151.77% |
| Foreign Exchange rate Adjustments | -31.25% | -101.74% | 192.09% | -93.50% | 143.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -259.13% | 91.90% | 329.70% | 338.26% | 458.92% |